Chief Investigator: Professor Helen Marshall AM

Funding Amount : $90,000

Recipient: The University of Adelaide

Overview: COVID-19 vaccination is recommended for pregnant women at any gestational age to decrease the risks of SARS-CoV-2 infection for both the woman and her baby. Young infants are at higher risk of severe COVID-19 disease compared to children, but are not eligible to receive a COVID-19 vaccine. Therefore, antibodies that pass from the mother to the infant via the placenta and breast milk would be the only protection the infants receive. This study aims to identify the best time to provide a booster dose to pregnant women in order to achieve maximum protection in infants.